Cat. No.: X22-05-ZQ464
Officinalisinin I
Synonym: 57944-18-0; Officinalisinin I; (2R,3R,4S,5S,6R)-2-[4-[(1R,2S,4S,6R,7S,8R,9S,12S,13S,16S,18R)-16-[(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-Hydroxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- CAS Number: 57944-18-0
- Compound CID: 102482481
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Properties
Description
Officinalisinin I is a steroid that has been shown to have antidiabetic, anti-inflammatory, and antioxidant. This product is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Molecular Formula
C45H76O19
Source
Anemarrhena asphodeloides
Purity
≥98%, determined by HPLC.
Solubility
It is soluble in water, methanol, acetonitrile aqueous solution.
Identity
Confirmed by MS and NMR.
Applications
Officinalisinin I is widely used in research in the fields of pharmaceuticals, cosmetics and health products.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products